medmix AG (SIX: MEDX.SW) Stock Competitors & Peer Comparison
See MEDX.SW's competitors and their performance on the SIX and across the wider stock market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MEDX.SW and its SIX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDX.SW | CHF 10.34 | +0.39% | 420.9M | 4308.33 | CHF 0.00 | +0.97% |
| SCHN.SW | CHF 286.50 | +8.73% | 31.3B | 29.81 | CHF 9.61 | +2.32% |
| SCHP.SW | CHF 292.80 | +8.52% | 31.3B | 30.89 | CHF 9.48 | +2.32% |
| VACN.SW | CHF 570.00 | -5.94% | 17.1B | 80.39 | CHF 7.09 | +1.23% |
| BEAN.SW | CHF 738.50 | -6.10% | 9.1B | 44.25 | CHF 16.69 | +1.35% |
| RAA.SW | CHF 615.00 | +0.00% | 7.7B | 48.08 | CHF 12.79 | +2.20% |
| ACLN.SW | CHF 64.60 | -5.00% | 6.1B | 29.23 | CHF 2.21 | +2.32% |
| SUN.SW | CHF 169.70 | -3.52% | 5.7B | 18.92 | CHF 8.97 | +2.80% |
| GF.SW | CHF 56.80 | -2.66% | 4.7B | -33.87 | -CHF 1.68 | +2.38% |
| KGX.SW | CHF 32.89 | -13.29% | 4.3B | 12.57 | CHF 2.62 | +1.77% |
Stock Comparison
Schindler Holding AG (SIX: SCHN.SW)
MEDX.SW vs SCHN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, SCHN.SW has a market cap of 31.3B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while SCHN.SW trades at CHF 286.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas SCHN.SW's P/E ratio is 29.81. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to SCHN.SW's ROE of +0.27%. Regarding short-term risk, MEDX.SW is less volatile compared to SCHN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check SCHN.SW's competition here
Schindler Holding AG (SIX: SCHP.SW)
MEDX.SW vs SCHP.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, SCHP.SW has a market cap of 31.3B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while SCHP.SW trades at CHF 292.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas SCHP.SW's P/E ratio is 30.89. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to SCHP.SW's ROE of +0.27%. Regarding short-term risk, MEDX.SW is less volatile compared to SCHP.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check SCHP.SW's competition here
VAT Group AG (SIX: VACN.SW)
MEDX.SW vs VACN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, VACN.SW has a market cap of 17.1B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while VACN.SW trades at CHF 570.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas VACN.SW's P/E ratio is 80.39. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to VACN.SW's ROE of +0.28%. Regarding short-term risk, MEDX.SW is less volatile compared to VACN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check VACN.SW's competition here
BELIMO Holding AG (SIX: BEAN.SW)
MEDX.SW vs BEAN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, BEAN.SW has a market cap of 9.1B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while BEAN.SW trades at CHF 738.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas BEAN.SW's P/E ratio is 44.25. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BEAN.SW's ROE of +0.33%. Regarding short-term risk, MEDX.SW is less volatile compared to BEAN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BEAN.SW's competition here
Rational AG (SIX: RAA.SW)
MEDX.SW vs RAA.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, RAA.SW has a market cap of 7.7B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while RAA.SW trades at CHF 615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas RAA.SW's P/E ratio is 48.08. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to RAA.SW's ROE of +0.28%. Regarding short-term risk, MEDX.SW is more volatile compared to RAA.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check RAA.SW's competition here
Accelleron Industries AG (SIX: ACLN.SW)
MEDX.SW vs ACLN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, ACLN.SW has a market cap of 6.1B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while ACLN.SW trades at CHF 64.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas ACLN.SW's P/E ratio is 29.23. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to ACLN.SW's ROE of +0.58%. Regarding short-term risk, MEDX.SW is less volatile compared to ACLN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check ACLN.SW's competition here
Sulzer Ltd (SIX: SUN.SW)
MEDX.SW vs SUN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, SUN.SW has a market cap of 5.7B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while SUN.SW trades at CHF 169.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas SUN.SW's P/E ratio is 18.92. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to SUN.SW's ROE of +0.23%. Regarding short-term risk, MEDX.SW is less volatile compared to SUN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check SUN.SW's competition here
Georg Fischer AG (SIX: GF.SW)
MEDX.SW vs GF.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, GF.SW has a market cap of 4.7B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while GF.SW trades at CHF 56.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas GF.SW's P/E ratio is -33.87. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to GF.SW's ROE of +8.38%. Regarding short-term risk, MEDX.SW is more volatile compared to GF.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check GF.SW's competition here
Kion Group AG (SIX: KGX.SW)
MEDX.SW vs KGX.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, KGX.SW has a market cap of 4.3B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while KGX.SW trades at CHF 32.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas KGX.SW's P/E ratio is 12.57. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KGX.SW's ROE of +0.06%. Regarding short-term risk, MEDX.SW is more volatile compared to KGX.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check KGX.SW's competition here
Jungheinrich AG (SIX: JUNGH.SW)
MEDX.SW vs JUNGH.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, JUNGH.SW has a market cap of 3.5B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while JUNGH.SW trades at CHF 30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas JUNGH.SW's P/E ratio is 11.61. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to JUNGH.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to JUNGH.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check JUNGH.SW's competition here
KUKA AG (SIX: KU2.SW)
MEDX.SW vs KU2.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, KU2.SW has a market cap of 3.3B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while KU2.SW trades at CHF 53.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas KU2.SW's P/E ratio is 36.60. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KU2.SW's ROE of +0.05%. Regarding short-term risk, MEDX.SW is not fully comparable compared to KU2.SW. This indicates unavailable risk data in terms of short-term price fluctuations for MEDX.SW.Check KU2.SW's competition here
Bucher Industries AG (SIX: BUCN.SW)
MEDX.SW vs BUCN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, BUCN.SW has a market cap of 3.2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while BUCN.SW trades at CHF 323.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas BUCN.SW's P/E ratio is 17.71. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BUCN.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to BUCN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check BUCN.SW's competition here
Kardex Holding AG (SIX: KARN.SW)
MEDX.SW vs KARN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, KARN.SW has a market cap of 1.9B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while KARN.SW trades at CHF 245.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas KARN.SW's P/E ratio is 73.47. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KARN.SW's ROE of +0.11%. Regarding short-term risk, MEDX.SW is more volatile compared to KARN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check KARN.SW's competition here
OC Oerlikon Corporation AG (SIX: OERL.SW)
MEDX.SW vs OERL.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, OERL.SW has a market cap of 1.8B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while OERL.SW trades at CHF 5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas OERL.SW's P/E ratio is 5.46. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to OERL.SW's ROE of +0.32%. Regarding short-term risk, MEDX.SW is less volatile compared to OERL.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check OERL.SW's competition here
Burckhardt Compression Holding AG (SIX: BCHN.SW)
MEDX.SW vs BCHN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, BCHN.SW has a market cap of 1.6B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while BCHN.SW trades at CHF 471.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas BCHN.SW's P/E ratio is 14.46. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BCHN.SW's ROE of +0.33%. Regarding short-term risk, MEDX.SW is less volatile compared to BCHN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BCHN.SW's competition here
Interroll Holding AG (SIX: INRN.SW)
MEDX.SW vs INRN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, INRN.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while INRN.SW trades at CHF 1,388.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas INRN.SW's P/E ratio is 21.20. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to INRN.SW's ROE of +0.11%. Regarding short-term risk, MEDX.SW is more volatile compared to INRN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check INRN.SW's competition here
Ballard Power Systems Inc. (SIX: BLD.SW)
MEDX.SW vs BLD.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, BLD.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while BLD.SW trades at CHF 3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas BLD.SW's P/E ratio is -6.66. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BLD.SW's ROE of -0.37%. Regarding short-term risk, MEDX.SW is more volatile compared to BLD.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check BLD.SW's competition here
Heidelberger Druckmaschinen AG (SIX: HDD.SW)
MEDX.SW vs HDD.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, HDD.SW has a market cap of 426.1M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while HDD.SW trades at CHF 1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas HDD.SW's P/E ratio is -79.91. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to HDD.SW's ROE of -0.01%. Regarding short-term risk, MEDX.SW is more volatile compared to HDD.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check HDD.SW's competition here
Phoenix Mecano AG (SIX: PM.SW)
MEDX.SW vs PM.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, PM.SW has a market cap of 402.4M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while PM.SW trades at CHF 419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas PM.SW's P/E ratio is 13.71. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to PM.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to PM.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check PM.SW's competition here
Phoenix Mecano AG (SIX: PMN.SW)
MEDX.SW vs PMN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, PMN.SW has a market cap of 399.7M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while PMN.SW trades at CHF 435.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas PMN.SW's P/E ratio is 14.22. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to PMN.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to PMN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check PMN.SW's competition here
Komax Holding AG (SIX: KOMN.SW)
MEDX.SW vs KOMN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, KOMN.SW has a market cap of 392.6M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while KOMN.SW trades at CHF 76.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas KOMN.SW's P/E ratio is -41.86. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KOMN.SW's ROE of -0.03%. Regarding short-term risk, MEDX.SW is less volatile compared to KOMN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check KOMN.SW's competition here
Meier Tobler Group AG (SIX: MTG.SW)
MEDX.SW vs MTG.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, MTG.SW has a market cap of 378.9M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while MTG.SW trades at CHF 35.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas MTG.SW's P/E ratio is 25.54. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to MTG.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to MTG.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check MTG.SW's competition here
Bystronic AG (SIX: BYS.SW)
MEDX.SW vs BYS.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, BYS.SW has a market cap of 322.4M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while BYS.SW trades at CHF 177.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas BYS.SW's P/E ratio is -8.85. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BYS.SW's ROE of -0.07%. Regarding short-term risk, MEDX.SW is less volatile compared to BYS.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BYS.SW's competition here
Mikron Holding AG (SIX: MIKN.SW)
MEDX.SW vs MIKN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, MIKN.SW has a market cap of 253.7M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while MIKN.SW trades at CHF 15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas MIKN.SW's P/E ratio is 9.05. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to MIKN.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to MIKN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check MIKN.SW's competition here
Starrag Group Holding AG (SIX: STGN.SW)
MEDX.SW vs STGN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, STGN.SW has a market cap of 196.1M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while STGN.SW trades at CHF 35.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas STGN.SW's P/E ratio is 13.55. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to STGN.SW's ROE of +0.05%. Regarding short-term risk, MEDX.SW is more volatile compared to STGN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check STGN.SW's competition here
Tornos Holding AG (SIX: TOHN.SW)
MEDX.SW vs TOHN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, TOHN.SW has a market cap of 101M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while TOHN.SW trades at CHF 5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas TOHN.SW's P/E ratio is 8.53. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to TOHN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is less volatile compared to TOHN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check TOHN.SW's competition here
Rieter Holding AG (SIX: RIEN.SW)
MEDX.SW vs RIEN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, RIEN.SW has a market cap of 92.8M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while RIEN.SW trades at CHF 2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas RIEN.SW's P/E ratio is -0.97. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to RIEN.SW's ROE of -0.13%. Regarding short-term risk, MEDX.SW is less volatile compared to RIEN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check RIEN.SW's competition here
Klingelnberg AG (SIX: KLIN.SW)
MEDX.SW vs KLIN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, KLIN.SW has a market cap of 92.8M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while KLIN.SW trades at CHF 10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas KLIN.SW's P/E ratio is 17.96. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to KLIN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is more volatile compared to KLIN.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check KLIN.SW's competition here
NORMA Group SE (SIX: NOEJ.SW)
MEDX.SW vs NOEJ.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, NOEJ.SW has a market cap of 70M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while NOEJ.SW trades at CHF 14.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas NOEJ.SW's P/E ratio is -8.83. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to NOEJ.SW's ROE of +0.34%. Regarding short-term risk, MEDX.SW is more volatile compared to NOEJ.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check NOEJ.SW's competition here
Perrot Duval Holding S.A. (SIX: PEDU.SW)
MEDX.SW vs PEDU.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, PEDU.SW has a market cap of 26.3M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while PEDU.SW trades at CHF 110.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas PEDU.SW's P/E ratio is -3.75. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to PEDU.SW's ROE of -0.49%. Regarding short-term risk, MEDX.SW is more volatile compared to PEDU.SW. This indicates higher risk in terms of short-term price fluctuations for MEDX.SW.Check PEDU.SW's competition here
Schlatter Industries AG (SIX: STRN.SW)
MEDX.SW vs STRN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, STRN.SW has a market cap of 23.2M. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while STRN.SW trades at CHF 21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas STRN.SW's P/E ratio is 66.86. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to STRN.SW's ROE of +0.01%. Regarding short-term risk, MEDX.SW is less volatile compared to STRN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check STRN.SW's competition here
Bobst Group S.A. (SIX: BOBNN.SW)
MEDX.SW vs BOBNN.SW Comparison October 2026
medmix AG (SIX: MEDX.SW) plays a significant role within the Industrials sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 420.9M. In comparison, BOBNN.SW has a market cap of 0. Regarding current trading prices, MEDX.SW is priced at CHF 10.34 on the SIX, while BOBNN.SW trades at CHF 57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of 4308.33, whereas BOBNN.SW's P/E ratio is N/A. In terms of profitability, MEDX.SW's ROE is +0.00%, compared to BOBNN.SW's ROE of +0.17%. Regarding short-term risk, MEDX.SW is less volatile compared to BOBNN.SW. This indicates lower risk in terms of short-term price fluctuations for MEDX.SW.Check BOBNN.SW's competition here